Breakthrough in Lung Cancer: Imfinzi’s FDA Approval for Limited-Stage SCLC Patients
AstraZeneca’s (AZ) Imfinzi (durvalumab) has received approval from the US Food and Drug Administration (FDA) for treating adults…
Abbreviated New Drug Application
Early Signs of Parkinson’s Disease You Shouldn’t Ignore
We recognize the invaluable role that care partners play in the lives of those impacted by Parkinson’s disease…
Lepu biotech: Breakthrough efficacy of PD-1 + EGFR ADC in nasopharyngeal cancer
The European Society for Medical Oncology (ESMO) Asia Congress will be held in Singapore. Lepu Biotech will present…
Indoco Remedies receives final ANDA approval from USFDA for Varenicline Tablets, 0.5 mg and 1 mg
Indoco Remedies Ltd. announced the final approval of the Company’s Abbreviated NewDrug Application (ANDA) for Varenicline Tablets, 0.5…
Abryl Laboratories Achieves Milestone with Regadenoson Injection ANDA Approval
Abryl Laboratories announced the approval of its Abbreviated New Drug Application (ANDA) for Regadenoson Injection in pre-filled syringes.…